WuXi AppTec (OTCMKTS:WUXAY) Shares Gap Up – What’s Next?
by Jessica Moore · The Cerbat GemWuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report)’s stock price gapped up before the market opened on Monday . The stock had previously closed at $15.60, but opened at $16.66. WuXi AppTec shares last traded at $16.66, with a volume of 200 shares changing hands.
Wall Street Analysts Forecast Growth
Separately, Zacks Research raised shares of WuXi AppTec to a “hold” rating in a research report on Monday, April 13th. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy”.
Check Out Our Latest Report on WUXAY
WuXi AppTec Stock Performance
The firm’s fifty day moving average price is $16.41 and its 200 day moving average price is $15.04.
WuXi AppTec (OTCMKTS:WUXAY – Get Free Report) last announced its quarterly earnings data on Monday, April 27th. The company reported $0.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.18 by $0.05. The firm had revenue of $1.82 billion for the quarter, compared to analysts’ expectations of $1.59 billion.
About WuXi AppTec
WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.
Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.